Description

Sonapax (thioridazine hydrochloride) Coated Tablets 10 mg. №60

Ingredients

Active ingredient: Thioridazine hydrochloride. Inactive ingredients: Lactose, corn starch, talc, magnesium stearate, hypromellose, titanium dioxide, and polyethylene glycol.

Dosage

Adults: The usual starting dose is 10 mg 2-3 times a day. Dosage may be gradually increased under medical supervision. Children: Dosage is based on weight and must be determined by a healthcare provider.

Indications

Sonapax is indicated for the management of schizophrenia. It helps control symptoms such as hallucinations, delusions, and disorganized thinking.

Contraindications

Do not use Sonapax if: allergic to thioridazine or any inactive ingredients, have a history of certain heart problems, or are taking certain medications. Consult a healthcare provider before use.

Directions

Take Sonapax exactly as prescribed by your healthcare provider. Do not adjust the dosage without medical advice. Swallow the tablets whole with a full glass of water. Do not crush or chew the tablets.

Scientific Evidence

Thioridazine, the active ingredient in Sonapax, is an antipsychotic medication that works by altering the effects of certain chemicals in the brain. Studies have shown thioridazine to be effective in managing symptoms of schizophrenia and other psychotic disorders. Research published in the Journal of Clinical Psychopharmacology demonstrated the efficacy of thioridazine in reducing positive symptoms of schizophrenia.

Additional Information

It is important to attend regular follow-up appointments with your healthcare provider while taking Sonapax to monitor your progress and any potential side effects. Avoid alcohol while on Sonapax as it can increase the risk of side effects. Inform your doctor about all medications, vitamins, and supplements you are taking before starting Sonapax.

Pharmacological Effects: Thioridazine exerts its antipsychotic effects by blocking dopamine receptors in the brain, specifically the D2 receptors. By modulating dopamine activity, thioridazine helps alleviate symptoms of schizophrenia.

Clinical Trials: Clinical trials have demonstrated the efficacy of thioridazine in managing schizophrenia. A study published in the Journal of Clinical Psychopharmacology compared thioridazine with other antipsychotic medications and found it to be equally effective in controlling symptoms with a lower risk of extrapyramidal side effects.